Breast cancer cells with acquired antiestrogen resistance are sensitized to cisplatin-induced cell death. [electronic resource]
- Molecular cancer therapeutics Jun 2007
- 1869-76 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1535-7163
10.1158/1535-7163.MCT-07-0072 doi
Antineoplastic Agents--pharmacology Blotting, Western Breast Neoplasms--pathology Caspases--metabolism Cell Death--drug effects Cell Line, Tumor Cisplatin--pharmacology Estrogen Receptor Modulators--pharmacology Humans Peptide Hydrolases--metabolism